Abstract
Abstract Recently, the first results were disclosed from a trial carried out by the National Surgical Adjuvant Breast and Bowel Project (NSABP) to evaluate the efficacy of breast conservation. These observations indicate that lumpectomy and axillary dissection plus radiation can be employed instead of total mastectomy for the treatment of a large proportion of women with primary breast cancer. The present report describes the technique of operation (lumpectomy), how the pathological examination of the resected specimen is carried out, and the manner in which radiation therapy is administered to the operated breast. The methodologies are those utilized in more than 1,200 women who for almost a decade have been participants in the NSABP study. It is emphasized that the outcome of patients exposed to breast preservation relates to the expertise of the surgeon, pathologist, and radiation and medical oncologists. The orchestration of care that will result in a satisfactory cosmesis and control of disease in the breast is more complex than is necessary for carrying out a mastectomy. Above all it is emphasized that, although the Halstedian concept for cancer surgery has been displaced, that change does not provide the imprimatur for haphazard surgery .
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Abreast in a boat--a race against breast cancer.
Many patients trying to get back to “real life” after a serious illness are disheartened to find that the post-treatment phase of their care is sadly wanting. Survivors of breas...
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Findings from this and other NSABP studies indicate that patients with breast cancer who meet NSABP protocol criteria, regardless of age, lymph node status, tumor size, or estro...
Reasons Why Women Who Have Mastectomy Decide to Have or Not to Have Breast Reconstruction
Breast reconstruction after mastectomy is chosen by approximately 10 percent of Australian women. Younger women are more likely to have this surgical procedure. This suggests th...
Factors that influence surgical choices in women with breast carcinoma
Abstract BACKGROUND In the absence of medical contraindications, survival after undergoing breast‐conserving therapy (BCT), mastectomy (M), and mastectomy with immediate reconst...
Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer
Five years of adjuvant tamoxifen is more beneficial than 2 years in the treatment of postmenopausal women with estrogen receptor-positive, early stage, invasive breast cancer.
Publication Info
- Year
- 1985
- Type
- article
- Volume
- 9
- Issue
- 5
- Pages
- 692-698
- Citations
- 70
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1007/bf01655182
- PMID
- 4060746